Literature DB >> 21567121

Increased glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma.

Mikiko Nakamura1, Yoshimasa Kitagawa, Yutaka Yamazaki, Hironobu Hata, Motoko Kotsuji, Yasuhisa Fujibayashi, Hidehiko Okazawa, Yoshiharu Yonekura, Kazuo Sano.   

Abstract

Hypoxia is known to have been related with angiogenesis and glycolysis, and may have an influence on tumor treatment effect. Because glucose utilization is higher in malignant cells than that in normal cells, dynamic glucose metabolism of tumor has been evaluated by means of [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET). To investigate the significance of tumor vascularization in oral squamous cell carcinoma, we compared tumor angiogenesis with the FDG-PET findings. Twenty patients underwent FDG-PET. For the quantitative evaluation of FDG uptake in each tumor, the mean standardized uptake value (SUV) was calculated. Microvessel structures labeled with CD34 antigen were investigated in pretreatment biopsy specimens. Using an image analyzer, we calculated the following microvessel parameters: the ratio of the total number of microvessels (TN) to tumor area (TA), the ratio of the total microvessel perimeter (TP) to the TA, and the ratio of the tumor tissue area more than 150 μm distant from each microvessel (hypoxic ratio, %). The SUV was compared with the above parameters. Simple regression analysis revealed a statistical significance between the SUV and the TN:TA ratio (p = 0.046), as well as between the SUV and the TP:TA ratio (p = 0.0206). The SUV was found to be inversely related to the TN:TA and TP:TA ratios. Elevated glucose metabolism assessed by FDG-PET correlated with reduced vascularization. Higher glucose metabolism might therefore reflect a state of hypoxia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567121     DOI: 10.1007/s10266-011-0024-3

Source DB:  PubMed          Journal:  Odontology        ISSN: 1618-1247            Impact factor:   2.634


  32 in total

1.  Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma.

Authors:  Gino Marioni; Filippo Marino; Luciano Giacomelli; Claudia Staffieri; Maria Livia Mariuzzi; Elena Violino; Cosimo De Filippis
Journal:  Acta Otolaryngol       Date:  2006-06       Impact factor: 1.494

2.  FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.

Authors:  Yoshimasa Kitagawa; Kazuo Sano; Sadahiko Nishizawa; Mikiko Nakamura; Toshiyuki Ogasawara; Norihiro Sadato; Yoshiharu Yonekura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-26       Impact factor: 9.236

3.  Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation.

Authors:  G Helmlinger; F Yuan; M Dellian; R K Jain
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

4.  Microvessel density predicts the radiosensitivity of metastatic head and neck squamous cell carcinoma in cervical lymph nodes.

Authors:  Y Ito; T Kamijo; T Yokose; M Kawashima; T Ogino; H Ikeda; R Hayashi; S Sasaki; A Ochiai
Journal:  Int J Oncol       Date:  2001-12       Impact factor: 5.650

5.  Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism.

Authors:  Ukihide Tateishi; Hiroshi Nishihara; Eriko Tsukamoto; Toshiaki Morikawa; Nagara Tamaki; Kazuo Miyasaka
Journal:  J Comput Assist Tomogr       Date:  2002 Mar-Apr       Impact factor: 1.826

6.  A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities.

Authors:  Kyoko Hida; Michael Klagsbrun
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

Review 7.  Hypoxia in head and neck cancer.

Authors:  A Y Isa; T H Ward; C M L West; N J Slevin; J J Homer
Journal:  Br J Radiol       Date:  2006-07-19       Impact factor: 3.039

8.  FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.

Authors:  Y Kitagawa; N Sadato; H Azuma; T Ogasawara; M Yoshida; Y Ishii; Y Yonekura
Journal:  J Nucl Med       Date:  1999-07       Impact factor: 10.057

9.  Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models.

Authors:  Nicolas Christian; Stéphanie Deheneffe; Anne Bol; Marc De Bast; Daniel Labar; John A Lee; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2010-03-19       Impact factor: 6.280

10.  Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity.

Authors:  Qiangming Sun; Hua Zhou; Nada O Binmadi; John R Basile
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

View more
  1 in total

1.  HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma.

Authors:  Jason C Fleming; Jeongmin Woo; Karwan Moutasim; Massimiliano Mellone; Steven J Frampton; Abbie Mead; Waseem Ahmed; Oliver Wood; Hollie Robinson; Matthew Ward; Christopher H Woelk; Christian H Ottensmeier; Emma King; Dae Kim; Jeremy P Blaydes; Gareth J Thomas
Journal:  Br J Cancer       Date:  2019-01-17       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.